Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DILZ67
|
|||
| Drug Name |
HB-202
|
|||
| Indication | Squamous cell carcinoma [ICD-11: 2B60-2D01; ICD-10: C44; ICD-9: 199] | Phase 1/2 | [1] | |
| Company |
Hookipa Pharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04180215) A Study of TheraT Vector(s) Expressing HPV 16+ in Patients With HPV 16+ Confirmed Cancers. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.